Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 303 | 360 | 256 | 329 | 203 |
| Cost of Goods | 386 | 474 | 465 | 448 | 460 |
| Gross Profit | -83 | -114 | -209 | -119 | -257 |
| Operating Expenses | 4,700 | 4,423 | 3,532 | 4,260 | 4,639 |
| Operating Income | -4,397 | -4,063 | -3,276 | -3,931 | -4,436 |
| Interest Expense | 9 | 4 | 0 | 0 | 368 |
| Other Income | 0 | 78 | 2 | -23 | -2,554 |
| Pre-tax Income | -4,406 | -3,989 | -3,274 | -3,954 | -7,358 |
| Net Income Continuous | -4,406 | -3,989 | -3,274 | -3,954 | -7,358 |
| Net Income Discontinuous | -4,757 | -20,857 | -1,187 | -232 | -8 |
| Net Income | $-9,163 | $-24,846 | $-4,461 | $-4,186 | $-7,366 |
| EPS Basic Total Ops | -1.58 | 3.99 | -0.77 | -0.70 | -11.55 |
| EPS Basic Continuous Ops | -0.76 | 8.66 | -0.57 | -0.65 | -11.55 |
| EPS Basic Discontinuous Ops | -0.82 | -4.66 | -0.20 | -0.05 | -0.01 |
| EPS Diluted Total Ops | -1.58 | 3.99 | -0.77 | -0.70 | -11.55 |
| EPS Diluted Continuous Ops | -0.76 | 8.66 | -0.57 | -0.65 | -11.55 |
| EPS Diluted Discontinuous Ops | -0.82 | -4.66 | -0.20 | -0.05 | -0.01 |
| EPS Diluted Before Non-Recurring Items | -0.75 | N/A | -0.75 | N/A | N/A |
| EBITDA(a) | $-4,157 | $-3,630 | $-2,978 | $-3,851 | $-4,193 |